KALA BIO, Inc. Income Statement
KALA|1 years of annual SEC 10-K data (FY2017-FY2017)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
KALA BIO, Inc. reported $45,000 in revenue and $17M in net loss for FY2017. Its profit margin was -37071.1% in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 |
|---|---|
| Revenue | $45.0K |
| SG&A Expense | $4.6M |
| R&D Expense | $11.4M |
| Operating Income | -$15.9M |
| Interest Expense | $604.0K |
| Income Tax | $0 |
| Net Income | -$16.7M |
| EPS (Diluted) | -$14.89 |
| Shares Outstanding | 1.2M |
| Operating Margin | -35435.6% |
| Profit Margin | -37071.1% |